Sino Biopharmaceutical Limited/ADR (SBMFF) Executive Compensation
Access SEC EDGAR filings, financial statements, 10-K, 10-Q, 8-K reports, auditor information, and financial intelligence for Sino Biopharmaceutical Limited/ADR (SBMFF).
Ticker: SBMFF
CIK: 1604982
Exchange: OTC
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PCAOB Registered Accounting Firm
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| F-6 POS | 2026-04-06 | — | F-6 POS | 0001019155-26-000147 | View SEC Doc Filr Page |
| F-6EF | 2020-01-24 | — | FORM F-6EF | 0001019155-20-000020 | View SEC Doc Filr Page |
| F-6EF | 2019-11-22 | — | F-6EF Filing | 0001193805-19-001656 | View SEC Doc Filr Page |
| F-6 POS | 2017-09-29 | — | F-6 POS Filing | 0001193805-17-002605 | View SEC Doc Filr Page |
| F-6EF | 2016-09-13 | — | F-6EF Filing | 0001193805-16-003943 | View SEC Doc Filr Page |
| F-6EF | 2016-05-25 | — | F-6EF Filing | 0001193805-16-003321 | View SEC Doc Filr Page |
| F-6EF | 2014-04-08 | — | F-6EF Filing | 0001193805-14-000751 | View SEC Doc Filr Page |